Table 2.
Classification studies published in the last few years
| Sample | References | Technology | Data | Algorithm | Biological condition |
|---|---|---|---|---|---|
| Urine | Dawson et al. (2012) | MALDI | Proteins/peptides | SVM | Ischemic stroke |
| Serum | Timms et al. (2011) | MALDI | – | – | Ovarian cancer |
| Virus | Wong et al. (2010) | MALDI | Spectra | Bayes classifiers | Influenza viruses |
| Tissues | Le Faouder et al. (2011) | MALDI-IMS | Protein peaks | SVM | Carcinoma |
| Tissues | M’Koma et al. (2011) | MALDI-IMS | Protein Peaks | k-nearest-neighbor | Colitis |
| Tissues | Djidja et al. (2010) | MALDI-IMS | Proteins/peptides | PCA-DA | Tumor |
| Acinetobacter spp. | Alvarez-Buylla et al. (2012) | MALDI | – | – | Acinetobacter spp. |
| Serum | Fan et al. (2012) | MALDI | Raw data | SVM | Breast cancer |
| Plasma | Fassbender et al. (2012) | MALDI | – | SVM | Endometriosis |
| Cerebrospinal fluid | Ishigami et al. (2012) | MALDI | Spectra | SVM-PCA | Parkinson |
| Cerebrospinal fluid | Komori et al. (2012) | MALDI | Spectra | SVM-PCA | Multiple sclerosis disorder |
| Pollen | Krause et al. (2012) | MALDI | Spectra | – | Pollen |
| Tissue | Meding et al. (2012) | MALDI | Spectra | SVM –RF | Tumor |
| Serum | Pecks et al. (2012) | MALDI | – | Preeclampsia | |
| Bronchoal-veolar fluid | Frenzel et al. (2011) | MALDI | Protein peaks | SVM | ALI/ARDS |
| Urine | Gao et al. (2011) | MALDI | Protein peaks | SVM | – |
| Serum | Han (2010) | MALDI | Spectra profile | SVM | Hepatitis B |
| Tissue | Waloszczyk et al.(2011) | MALDI | Protein peaks | – | Lung cancer |
| Urine | Balog et al. (2010) | MALDI | Peptide | SVM | Schistosoma mansoni infection |
| Tissue | Kim et al. (2012) | MALDI | Spectra | SVM-PCA | Gastric cancer |
| Bacterial suspensions | Lasch et al. (2010) | MALDI | Spectra | ANN | Yersinia |
| Tissue | Liao et al. (2010) | MALDI | Spectra | k NN | Colorectal cancer |
| Serum | Camaggi et al. (2010) | MALDI | – | RF | Hepato carcinoma |
| Plasma | Lin et al.(2012) | SELDI | Protein peaks | PCA | Lung adenocarcinoma |
| Serum | Van Gorp et al. (2012) | SELDI | Protein peaks | LS-SVM | Lymph node status in cerebral cancer |
| Serum | Zhu et al. (2012) | SELDI | – | SVM | Pancreatic cancer |
| Endometrial samples | Kyama et al. (2011) | SELDI | Protein peaks | SVM | Endometriosis |
| Serum | Fan et al. (2010) | SELDI | Protein peaks | SVM | Breast cancer |
| Serum | Liu et al. (2010) | SELDI | Spectra | Decision tree | Tuberculosis |
| Serum | Tang et al. (2010) | SELDI | Spectra | Kernel PLS models | Ovarian cancer |
| Tissues | Wang et al. (2010) | SELDI | Spectra | ANN | Endometriosis |
| Serum | Song et al. (2012) | SELDI and ELISA | Protein peaks | SVM | Biliary atresia |
| Serum | Ahn et al. (2012) | Multiplex array | – | – | Gastric adenocarcinoma |
| Plasma | Izbicka et al. (2012) | Multiplex immunoassays | SVM | Lung cancer | |
| Tissue | Lazova et al. (2012) | IMS | Spectra | – | Spitzoid malignant melanoma |
| Serum | Sui et al.(2010) | – | – | Genetic algorithm | Urinemia |
SVM support virtual machine, ANN artificial neural network, PCA principal component analysis, DA discriminant analysis, RF random forest, PLS partial least square